Showing results (6011-6020 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 6, 2007
KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrinJuan J Calvete, Cezary Marcinkiewicz, Libia SanzCurrent Pharmaceutical Design|November 6, 2007
Non-lethal polypeptide components in cobra venomYuri N Utkin, Alexey V OsipovCurrent Pharmaceutical Design|November 6, 2007
Trends in snakebite envenomation therapy: scientific, technological and public health considerationsJosé María Gutiérrez, Bruno Lomonte, Guillermo León, et al.Current Pharmaceutical Design|November 6, 2007
Salivary defensins and their importance in oral health and diseaseYoshihiro Abiko, Masato SaitohCurrent Pharmaceutical Design|November 6, 2007
Antimicrobial peptides in oral cancerJens E Meyer, Jürgen HarderCurrent Pharmaceutical Design|November 6, 2007
Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metalsB Cvek, Z DvorakCurrent Pharmaceutical Design|June 23, 2007
Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implicationsH Wilms, L Zecca, P Rosenstiel, et al.Current Pharmaceutical Design|August 21, 2007
How to advise aspirin use in patients who need NSAIDsF Sopena, A LanasCurrent Pharmaceutical Design|August 21, 2007
Modulation of ion channels in pulmonary arterial hypertensionChristelle Guibert, Roger Marthan, Jean-Pierre SavineauCurrent Pharmaceutical Design|August 21, 2007
Eph/ephrin signaling as a potential therapeutic target after central nervous system injuryJ Du, C Fu, D W SretavanPageof 1,008